4//SEC Filing
Riggs Josh 4
Accession 0001493152-23-006302
CIK 0001642380other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:59 PM ET
Size
5.5 KB
Accession
0001493152-23-006302
Insider Transaction Report
Form 4
Riggs Josh
CEO and President
Transactions
- Award
Option to Purchase Common Stock
2023-02-24+116,426→ 116,426 totalExercise: $0.39Exp: 2033-02-24→ Common Stock (116,426 underlying)
Footnotes (1)
- [F1]One third of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0001956391
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:59 PM ET
- Size
- 5.5 KB